Open Actively Recruiting

First in Human Study of TORL-3-600 in Participants With Advanced Cancer

About

Brief Summary

This first-in-human study will evaluate the safety, tolerability, pharmacokinetics, and antitumor activity of TORL-3-600 in patients with advanced cancer

Primary Purpose
Treatment
Study Type
Interventional
Phase
Phase 1

Eligibility

Gender
All
Healthy Volunteers
No
Minimum Age
18 Years
Maximum Age
N/A

Inclusion Criteria:

Exclusion Criteria:

Join this Trial

Share:
Study Stats
Protocol No.
23-001082
Category
Bladder Cancer
Breast Cancer
Cervical Cancer
Colorectal Cancer
Esophageal Cancer
Head and Neck Cancer
Kidney Cancer
Liver Cancer
Lung Cancer
Other Cancer
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Stomach Cancer
Contact
LISA-MARIA YONEMOTO
Location
  • TRIO-US - Fullerton
  • UCLA San Luis Obispo
  • UCLA Santa Barbara
  • UCLA Santa Monica
  • UCLA Westwood
For Providers
NCT No.
NCT05948826
For detailed technical eligibility, visit ClinicalTrials.gov.